Suppr超能文献

二级预防对脑卒中患者认知功能的长期影响。

Long-term effects of secondary prevention on cognitive function in stroke patients.

机构信息

Division of Health and Social Care, King's College London, London, UK; and National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' NHS Trust and King's College London, London, UK.

出版信息

Circulation. 2013 Sep 17;128(12):1341-8. doi: 10.1161/CIRCULATIONAHA.113.002236. Epub 2013 Aug 9.

Abstract

BACKGROUND

Limited long-term follow-up data exist on the impact of appropriate secondary prevention therapies on cognitive function in patients after first-ever stroke. The aim of this study is to determine the effect of secondary prevention of vascular events on cognitive function after stroke.

METHODS AND RESULTS

Data were collected between 1995 and 2011 (n=4413) from the community-based South London Stroke Register covering an inner-city multiethnic source population of 271 817 inhabitants. Modified Poisson regression models were constructed to adjust for cognitive function status at 3 months, demographic and socioeconomic characteristics, case mix, stroke subtype, vascular risk factors, disability, and stroke recurrence. In patients with ischemic strokes without a history of atrial fibrillation (AF), there was a reduced risk of cognitive impairment associated with the use of different prevention treatments: (1) antihypertensives (relative risk, 0.7 [95% confidence interval, 0.57-0.82] for diuretics; relative risk, 0.8 [95% confidence interval, 0.64-0.98] for angiotensin-converting enzyme inhibitors; and relative risk, 0.7 [95% confidence interval, 0.55-0.81] for their combination), (2) a combination of aspirin and dipyridamole (relative risk, 0.8 [95% confidence interval, 0.68-1.01]), and (3) statin (relative risk, 0.9 [95% confidence interval, 0.76-1.06]) when clinically indicated. Protective effects against cognitive impairment were also observed in patients on the combination of antihypertensives, antithrombotic agents, and lipid-lowering drugs (relative risk, 0.55 [95% confidence interval, 0.40-0.77]). No significant associations were noted between poststroke cognitive impairment and antihypertensives among hemorrhagic stroke patients.

CONCLUSIONS

Appropriate vascular risk management was associated with a long-term reduced risk of cognitive impairment. Focus on optimal preventive drug therapy of vascular risk factors and management should be supported.

摘要

背景

首次发生卒中后,适当的二级预防治疗对认知功能的长期影响的数据有限。本研究旨在确定血管事件二级预防对卒中后认知功能的影响。

方法和结果

数据来自于 1995 年至 2011 年的社区为基础的南伦敦卒中登记处,涵盖了一个拥有 271817 居民的多民族城市核心人群。采用修正泊松回归模型,对 3 个月时的认知功能状况、人口统计学和社会经济学特征、病例组合、卒中亚型、血管危险因素、残疾和卒中复发进行调整。在没有房颤(AF)病史的缺血性卒中患者中,使用不同的预防治疗方法与认知障碍风险降低相关:(1)抗高血压药物(利尿剂的相对风险为 0.7[95%可信区间,0.57-0.82];血管紧张素转换酶抑制剂的相对风险为 0.8[95%可信区间,0.64-0.98];联合使用的相对风险为 0.7[95%可信区间,0.55-0.81]),(2)阿司匹林和双嘧达莫的联合使用(相对风险为 0.8[95%可信区间,0.68-1.01]),(3)他汀类药物(相对风险为 0.9[95%可信区间,0.76-1.06]),当临床上需要时。在接受抗高血压药物、抗血栓药物和降脂药物联合治疗的患者中,也观察到了对认知障碍的保护作用(相对风险为 0.55[95%可信区间,0.40-0.77])。在出血性卒中患者中,抗高血压药物与卒中后认知障碍之间无显著关联。

结论

适当的血管风险管理与长期认知障碍风险降低相关。应支持对血管危险因素和管理的最佳预防性药物治疗的关注。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验